Sat
Apr
29

Tag "BioMARC"

BioMARC secures $3 million from the Department of Defense to advance vaccine development

CSU’s vaccine manufacturing facility, BioMARC, is developing a drug to protect U.S. soldiers from a mosquito-borne pathogen that can cause severe illness and death.

Read More

BioMARC helps advance vaccines for Department of Defense

Colorado State University’s Biopharmaceutical Manufacturing and Academic Resource Center (BioMARC) has been awarded a 10-month, $4.6 million contract funded by the Department of Defense (DoD) to help develop and manufacture new vaccines to fight encephalitic viruses that cause inflammation of the brain.

Read More

CSU to make Ebola, Marburg vaccines to support human trials

BioMARC, a high-containment biopharmaceutical facility operated by CSU, is manufacturing the vaccines for the U.S. Department of Defense in support of human clinical trials.

Read More